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A14-year-oldpatientpresentedwithbilateralpneumoniaandpleuraleﬀusions,septicarthritisofthehip,deepvenousthrombosis,
and pulmonary thromboembolism. Methicillin-sensitive Staphylococcus aureus (S. aureus) containing the Panton Valentine
Leukocidin (PVL) genes was isolated. Contraindication to anticoagulation prompted inferior vena cava ﬁlter placement. He
completed4weeksoftreatmentwithﬂucloxacillin,withgoodclinicaloutcome.S.aureuscontainingPVLgenesshouldbesoughtin
cases of necrotizing pneumonia as it seems to increase the risk of severe multifocal infection and thrombotic complications. There
are few reports of placement of ﬁlters during S. aureus sepsis and bacteraemia. This case highlights that when anticoagulation is
not feasible, an inferior vena cava ﬁlter can be inserted safely, even in patients with active sepsis and high risk for seeding of the
ﬁlter. Long-term follow-up conﬁrmed a successful outcome with sterilization of the septic thrombosis with no further pulmonary
embolism or additional sepsis episodes.
1.Introduction
Staphylococcus aureus (S. aureus) may cause community-
acquired multifocal severe disease on otherwise healthy
children and adolescents. Multiple virulence factors have
been identiﬁed as important to the pathogenesis of infection
[1]. One of those factors is Panton-Valentine Leukocidin
(PVL), an exotoxin that destroys leukocytes by pore-forming
activity. Several studies have shown an association of S.
aureus containing PVL genes with a more severe inﬂamma-
tory response [2, 3] and clinically with necrotic skin lesions
and abscesses [4], arthritis/osteomyelitis complicated by
septic deep venous thrombosis [3, 5] and severe necrotizing
pneumonia[6].However,theroleofPVLinthepathogenesis
of community-acquired infections, especially in methicillin-
resistant strains, is still under discussion [1, 7, 8].
The management of major deep venous thrombosis
in septic patients may be diﬃcult. The high risk for
complications such as worsening sepsis, metastatic infection,
and pulmonary embolism, is an important argument to
consider placement of an inferior vena cava (IVC) ﬁlter.
Those complications also raise questions about the safety
and long-term eﬀectiveness of central venous ﬁlters, inserted
during active sepsis and bacteraemia. Greenﬁeld and Proctor
[9] reviewed 175 septic patients who received intravascular
ﬁlters and found no reports of patients with recurrent sepsis
episodesoranysigniﬁcantadverseevents.Ontheotherhand,
an IVC ﬁlter has been shown to become infected during
active sepsis [10].
Considering these issues, the authors report a case of safe
and eﬀective insertion of an IVC ﬁlter in a patient with septic
embolism with good long-term outcome.
2.CaseReport
A 14-year-old male adolescent had a toe trauma complicated
with local soft tissue infection and necrosis. Ten days later2 International Journal of Pediatrics
he presented with fever, cough, thoracic and right inguinal
pain. The physical exam revealed signs of minor respiratory
distress, 97% oxygen saturation on room air, decreased
breath sounds on the right, inﬂammatory signs of the
right lower leg, and a toe wound. Laboratory evaluation at
admission showed: leukocyte count 18.2 × 109/L with 91%
neutrophils,haemoglobin1.72mmol/L,platelets114×109/L,
and C-reactive protein 250mg/L. The chest radiograph
was consistent with bilateral pneumonia and minor pleural
eﬀusions. The venous doppler ultrasound conﬁrmed a deep
venous thrombosis (DVT) of the right femoral vein. Blood
cultureswereperformedandthepatientwasstartedonintra-
venous antibiotic therapy with piperacillin-tazobactam and
subcutaneous low-molecular weight heparin. The transtho-
racic echocardiogram revealed a good ventricular function
and no signs of cardiac vegetations.
On the third day after admission, thoracic pain and
respiratory distress increased. Considering the hypothesis of
septic pulmonary thromboembolism (PT) a chest computed
tomography (CT) was performed, showing bilateral thoracic
inﬁltrates and pleural eﬀusion. The diagnostic thoracocente-
sis revealed a pleural empyema.
Twelve hours later, the patient developed signs of shock
and was admitted to the paediatric intensive care unit
(PICU). Abdominal ultrasound revealed haemoperitoneum
and hepatic hematoma probably due to hepatic puncture
during thoracocentesis. Anticoagulation was stopped. A sec-
ond CT scan showed signs of pulmonary thromboembolism
and right hip ﬂuid collection suggestive of septic arthritis.
Dopplerstudiesofinferiorvenacavaandileo-femoralvessels
identiﬁed a large thrombus in the right iliac veins. The case
was discussed with the vascular surgeons and a low-proﬁle
percutaneously introducible IVC ﬁlter (titanium Greenﬁeld
ﬁlter, Medi-tech,W a t e r t o w n ,M A )w a sp l a c e d( Figure 1).
Simultaneously, right hip arthrotomy with debridment and
drainage was performed.
Methicillin-sensitive S. aureus was isolated from blood
cultures and synovial ﬂuid (Figure 2(a)) prompting antibi-
otictherapychangetoﬂucloxacillin.PVLgenes(lukS-PVand
lukF-PV) were detected on polymerase chain reaction (PCR)
assays (Figure 2(b)). Pleural ﬂuid had no microbiologic
isolation.
The patient completed four weeks of intravenous ﬂu-
cloxacillin with good clinical outcome, being afebrile since
the sixth day of antibiotic therapy. From a pulmonary
standpoint, the patient was stabilized two days after the
IVC ﬁlter placement, with no other respiratory distress or
thoracic pain episodes. Repeated abdominal ultrasounds in
the ﬁrst month after admission showed improvement of
haemoperitoneum.
Immunological studies were performed two months
after admission, when the patient had completely recov-
ered. Immunodeﬁciency was ruled out by normal levels of
immunoglobulins and phagocyte oxidative capacity (dihy-
drorhodamine assay).
The evaluation for venous thrombosis risk factors
revealed a common genetic polymorphism of the enzyme
methylenetetrahydrofolate reductase (MTHFR) with het-
erozygosity for 677C>T substitution and another heterozy-
Figure 1: Intraoperative angiography showing inferior vena cava
(IVC) ﬁlter placement.
gous polymorphism of plasminogen activator inhibitor 1
(PAI-1) locus with the allelic variant 675G>A( 4 G / 5 G ) ,
both tested with PCR assays. Other diagnostic work-up
for hypercoagulability yielded normal results (prothrombin
time, activated partial thromboplastin time; antiphospho-
lipid antibodies; levels of ﬁbrinogen, antithrombin III,
protein C, protein S; testing for factor V Leiden mutation,
and prothrombin G20210A mutation).
At 14 months of follow-up there were no other episodes
of fever or possible bacteraemia, IVC ﬁlter migration,
progressiveIVCthrombosis,pulmonaryembolism,orsignif-
icant hip joint dysfunction.
3. Discussion
It is known that S. aureus strains harbouring the PVL
genes are associated with complicated skin and soft tissue
infections [3, 5, 6]. PVL genes are also implicated in bone
and joint infections with a higher rate of deep venous
thrombosis [2, 5]. These ﬁndings are in accordance with the
severity of the community-acquired soft tissue infection in
our previously healthy patient, complicated with right hip
septic arthritis, right femoral venous thrombosis, septic PT,
and bilateral pneumonia. In a previous study, the occurrence
of septic PT in children infected with a S. aureus strain
containing PVL genes, represented 19% of the abnormal
pulmonary ﬁndings in these patients [6]. Deep venous
thrombosis should always be considered in patients who
present with a musculoskeletal infection and respiratory
symptoms, especially if a staphylococcal infection is possible.
Also an echocardiography should be routinely performed in
this clinical scenario, in spite of conﬂicting evidence on the
importance of isolated S. aureus bacteraemia and the risk of
endocarditis [6, 11, 12].
In the reported case the diagnostic work-up included
routine evaluation tests for immunodeﬁciency and throm-
bophilia. In spite of the known aggressiveness of S. aureus
strains harbouring the PVL genes, we believe that hereditary
host susceptibility for infection or thrombosis should beInternational Journal of Pediatrics 3
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Figure 2: PCR ampliﬁcation of mecA gene products (a) and the genes that code PVL (b) visualized on gel electrophoresis. (a) Lanes (L):
L1—mecA gene PCR kit; L2—Patient; L3—Positive Control. (b) Lanes (L): L1—PVL gene PCR kit; L2—Patient; L3—Positive Control.
sought, especially in young children or whenever there is
a family history. Our patient had two common polymor-
phisms of the MTHFR and PAI-1 genes. Although their
clinical signiﬁcance as risk factors for thromboembolic
events is uncertain, they might play a role when associated
with S. aureus infections.
When septic PT is diagnosed, prompt antimicrobial and
anticoagulation therapy should be instituted [5]. In our
patient, the anticoagulation had to be stopped because of
active bleeding, so a surgical/mechanical solution was sought
and an IVC ﬁlter was placed.
The signiﬁcant morbidity and mortality risk of acute dis-
seminated S. aureus disease after deep vein thrombophlebitis
is well recognized [13]. Remarkably, there are few reports of
placement of ﬁlters during S. aureus sepsis and bacteraemia
in children. A retrospective review [14] of 15 children 18
years or younger, suggested that long-standing vena cava ﬁl-
ters were safe and prevented pulmonary embolism, but none
was placed in the setting of infection. The Food and Drug
Administration guidanceforintravascularﬁlters[15] defends
thatsepsisandsepticembolismarecontraindicationsforIVC
ﬁlter placement.
An in vivo study of the eﬀectiveness of Greenﬁeld ﬁlters
in animals with infected thrombus, found that antibiotics
successfullysterilizedtheﬁlter,septicembolus,andvenacava
wall [16]. On the contrary, diﬀerent surgical options used in
thepast,likevenacavalligation,wereassociatedwithpockets
of infection and abscess, independently of antibiotic therapy
[17].
Gonzalez et al. [5] reviewed 3 patients with ﬁlter
placementaftervenousthrombosisinS.aureusosteomyelitis,
and found no ﬁlter migration, recurrent septic PT or IVC
thrombosis.
Greenﬁeld and Proctor [9] reviewed 175 septic patients
who received intravascular ﬁlters and demonstrated in their
study that the placement of ﬁlters during sepsis did not add
to the mortality and was an alternative when anticoagulation
was not feasible. The authors found no clinical reports
of patients requiring ﬁlter removal secondary to sepsis or
any other adverse events related to septicaemia following
ﬁlter placement. The good results may be associated with
the inert materials used in the Greenﬁeld ﬁlter (stainless
steel and titanium). In this way, only a trapped embolus
can become infected, a problem that is easily solved with
adequate antibiotic therapy. In spite of the signiﬁcant
number of patients included, these results may be biased
by the retrospective analysis and lack of speciﬁc outcomes
measure, with an important number of drop-outs on follow-
up evaluation (only 32% of the patients).
Also, one recent report describes IVC ﬁlter insertion in
a patient with Candida glabrata septic thrombophlebitis that
resulted in IVC ﬁlter infection [10].
We consider that a severe invasive infection is an
important risk factor for venous ﬁlter placement, but it
seems to be warranted for septic patients who are haemo-
dynamically unstable and cannot tolerate an additional
respiratory compromise associated with pulmonary emboli.
Theindications forthisprocedureinpaediatric sepsisshould
be reviewed, including signiﬁcant PT and contraindications
for anticoagulation, as in our patient. Risk factors for the
development of persistent bacteraemia/fungaemia must also
be weighted, such as prolonged intensive care unit stay,
other prostetic devices, immunosuppression, and antibiotic
resistance.
This case highlights the importance of considering S.
aureusstrainscontainingthePVLgenesastheetiologicagent4 International Journal of Pediatrics
when there are signs of bone, joint, or soft tissue infection
associated with severe pneumonia and thromboembolic
events. In this setting the placement of an IVC ﬁlter
may be a safe and eﬀective strategy to prevent PT when
anticoagulation is not indicated.
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